Biochemists and Biophysicists in Boston-Cambridge-Newton, MA-NH

Employers filed 326 applications covering 362 positions for this role here, at a median of $118,331 a year. 196 of those state a minimum and no maximum — a Labor Condition Application commits an employer to a floor, not to a salary.

What the government requires here

The prevailing wage for Biochemists and Biophysicists in Boston-Cambridge-Newton, MA-NH, wage year 2025-26 — the four levels an employer must meet depending on the experience the role demands.

Level	Who it is for	A year
Level I	Entry: a role needing basic understanding and close supervision	$79,581
Level II	Qualified: some experience, moderate supervision	$101,026
Level III	Experienced: sound understanding, limited supervision	$122,450
Level IV	Fully competent: judgement, may supervise others	$143,894

Who filed, and at what

Employer	Level	Filings	Positions	Median
Massachusetts Institute of Technology	Level I	21	21	$78,100
General Hospital Corporation	Level I	14	14	$76,134
Harvard University	Level I	9	9	$76,000
Children's Hospital Corporation	Level I	8	8	$73,544
Dana-Farber Cancer Institute	Level I	8	36	$73,500
General Hospital Corporation	Level II	7	7	$82,482
Brigham and Women's Hospital	Level I	5	5	$71,750
Brigham and Women's Hospital	Level II	5	5	$77,267
Eli Lilly and Company	Level IV	5	9	$175,289
Vertex Pharmaceuticals Incorporated	Level II	5	5	$120,000
CRISPR Therapeutics, Inc.	Level II	4	4	$112,922
Howard Hughes Medical Institute	Level II	4	4	$81,450
Massachusetts Eye and Ear Infirmary	Level I	4	4	$75,875
Brandeis University	Level I	3	3	$77,000
Bristol-Myers Squibb Company	Level IV	3	3	$155,196
The Broad Institute, Inc.	Level I	3	3	$65,775
Novartis Institutes for BioMedical Research, Inc.	Level II	3	3	$101,026
Sanofi US Services Inc.	Level I	3	3	$100,000
Serif Biomedicines, Inc.	Level II	3	3	$105,000
Strand Therapeutics Inc.	Level I	3	3	$79,581
AI Proteins, Inc.	Level III	2	2	$142,500
Alnylam US, Inc.	Level II	2	2	$132,000
Amgen Inc.	Level I	2	2	$90,151
Amgen Inc.	Level II	2	2	$129,875
Amgen Inc.	Level III	2	2	$138,353
AstraZeneca Pharmaceuticals LP	Level II	2	2	$141,544
Beth Israel Deaconess Medical Center,Inc.	Level I	2	2	$65,499
Boston Children's Network Specialty Physicians, Inc	Level I	2	2	$74,463
Brandeis University	Level II	2	2	$96,428
Eli Lilly and Company	Level III	2	2	$130,000
Entrada Therapeutics, Inc.	Level III	2	2	$157,248
Harvard University	Level II	2	2	$90,266
Lila Sciences, Inc.	Level I	2	2	$80,000
Lila Sciences, Inc.	Level II	2	2	$101,513
Massachusetts Institute of Technology	Level II	2	2	$85,842
PFIZER INC.	Level III	2	2	$130,005
Ring Therapeutics, Inc.	Level III	2	2	$182,754
Sanofi Pasteur Inc.	Level III	2	2	$122,450
Sanofi US Services Inc.	Level III	2	2	$135,475
Sanofi Vaccines US Inc.	Level II	2	2	$101,026
Solid Biosciences Inc.	Level IV	2	2	$150,000
TRUSTEES OF BOSTON UNIVERSITY	Level I	2	2	$69,830
Tufts University	Level I	2	2	$71,582
Visterra, Inc.	Level II	2	2	$102,000
WINDOW THERAPEUTICS, INC.	Level I	2	2	$105,000
WuXi AppTec Sales, LLC	Level III	2	2	$133,500
AbbVie Bioresearch Center Inc.	Level I	1	1	$88,680
AGIOS PHARMACEUTICALS, INC.	Level IV	1	1	$164,424
Amide Technologies, Inc.	Level II	1	1	$135,000
Ampersand Biomedicines, Inc.	Level I	1	1	$81,000
Ampersand Biomedicines, Inc.	Level II	1	1	$101,026
Antares Therapeutics, Inc.	Level IV	1	1	$190,000
Arranta Bio MA LLC	Level III	1	1	$169,093
AstraZeneca Pharmaceuticals LP	Level I	1	1	$138,511
Beth Israel Deaconess MedicalCenter,Inc.	Level II	1	1	$75,564
Biogen, Inc.	Level I	1	1	$79,581
Biogen, Inc.	Level III	1	1	$124,000
Biogen Inc.	Level IV	1	1	$145,000
Bioverativ Therapeutics, Inc.	Level I	1	1	$79,581
Brigham & Women's Faulkner Hospital	Level I	1	1	$70,000
Brigham and Women's Hospital	Level III	1	1	$79,040
The Broad Institute, Inc.	Level II	1	1	$70,000
The Broad Institute, Inc.	Level III	1	1	$147,900
BRUKER SPATIAL BIOLOGY	Level II	1	1	$120,000
Children's Hospital Corporation	Level II	1	1	$77,267
Children's Hospital Corporation	Level III	1	1	$87,000
CRISPR Therapeutics, Inc.	Level III	1	1	$125,000
Curia Global, Inc.	Level IV	1	1	$156,560
Dana-Farber Cancer Institute	Level II	1	1	$85,000
Dyne Therapeutics, Inc.	Level II	1	1	$141,010
Dyno Therapeutics, Inc.	Level II	1	1	$141,695
Eli Lilly and Company	Level I	1	5	$143,894
EMD Serono Research and Development Institute, Inc.	Level II	1	1	$117,577
Fable Therapeutics, Inc.	Level IV	1	1	$170,000
Flagship Pioneering, Inc.	Level IV	1	1	$180,000
General Hospital Corporation	Level III	1	1	$79,040
General Hospital Corporation	Level IV	1	1	$89,336
Generate Biomedicines, Inc.	Level III	1	1	$125,000
Generate Biomedicines, Inc.	Level IV	1	1	$175,000
Genezen MA, Inc.	Level I	1	1	$110,000
Genezen MA, Inc.	Level IV	1	1	$148,000
Ginkgo Bioworks, Inc.	Level IV	1	1	$143,894
Halozyme Hypercon, Inc.	Level II	1	1	$101,026
IM PRO MAKEUP NY LP	Level III	1	1	$160,000
IM PRO MAKEUP NY LP	Level IV	1	1	$160,000
Institute for Protein Innovation Inc.	Level III	1	1	$79,040
Invaio Sciences, Inc.	Level IV	1	1	$215,000
Janssen Research & Development, LLC	Level I	1	1	$127,608
KalVista Pharmaceuticals, Inc.	Level IV	1	1	$143,894
Kernal Biologics, Inc.	Level III	1	1	$160,000
Kymera Therapeutics, Inc.	Level II	1	1	$125,715
Massachusetts Eye and Ear Associates	Level I	1	1	$83,158
Massachusetts Eye and Ear Infirmary	Level III	1	1	$81,130
Massachusetts Institute of Technology	Level III	1	1	$79,040
Merck Research Laboratories Massachusetts, LLC	Level I	1	1	$131,400
Merck Research Laboratories Massachusetts, LLC	Level IV	1	1	$176,200
ModernaTX, Inc.	Level II	1	1	$101,026
ModernaTX, Inc.	Level III	1	1	$122,450
Nanopath Inc.	Level I	1	1	$102,000
Northeastern University	Level I	1	1	$86,990

Tell me when this moves

One email when the prevailing wage for Biochemists and Biophysicists in Boston-Cambridge-Newton, MA-NH changes — the library turns over every July, and what an employer must offer changes with it.

Source: OFLC disclosure data and prevailing wage library, US Department of Labor (public domain). Figures are what employers filed, not what they paid.